Takashi Kurita Keiko Ishida Emiri Muranaka Hiroki Sasazawa Haruki Mito Yudai Yano Ryota Hase
10.2169/internalmedicine.5394-20
Intern Med
2020;59(22):2951-2953.
coronavirus disease 2019 drug fever favipiravir
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/33191372/
Amides / adverse effects Betacoronavirus Coronavirus Infections / drug therapy Fever / chemically induced Pneumonia, Viral / drug therapy Pyrazines / adverse effects
Amides / adverse effects Betacoronavirus Coronavirus Infections / drug therapy Fever / chemically induced Pneumonia, Viral / drug therapy Pyrazines / adverse effects Case Reports Aged, 80 and over Amides / therapeutic use Antiviral Agents / adverse effects Antiviral Agents / therapeutic use COVID-19 Coronavirus Infections / epidemiology Humans Male Pandemics Pneumonia, Viral / epidemiology Pyrazines / therapeutic use SARS-CoV-2 Amides Antiviral Agents Pyrazines favipiravir
PMC7725626
33191372
A Favipiravir-induced Fever in a Patient with COVID-19
2020